Mestinon

A cholinesterase inhibitor with a slightly longer duration of action than neostigmine. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. .
[PubChem].

Medicinal name:
  • Pyridostigmine Bromide 180 MG Extended Release Oral Tablet [Mestinon]
  • Pyridostigmine Bromide 60 MG Oral Tablet [Mestinon]

Mestinon - Pharmacology:

Mestinon inhibits acetylcholinesterase in the synaptic cleft by competing with acetylcholine for attachment to acetylcholinesterase, thus slowing down the hydrolysis of acetylcholine, and thereby increases efficiency of cholinergic transmission in the neuromuscular junction and prolonges the effects of acetylcholine.

Mestinon mini report

Mestinon NDA
NDA - A product marketed under an approved New Drug Application
Mestinon SYRUP
SYRUP
Mestinon TABLET
TABLET
Mestinon TABLET, EXTENDED RELEASE
TABLET, EXTENDED RELEASE
Mestinon HUMAN PRESCRIPTION DRUG
HUMAN PRESCRIPTION DRUG
Mestinon global name
pyridostigmine bromide
Start - Stop data
START DATA:
1965-Jan-25
Start - Stop data
STOP DATA
not occurred

Mestinon Interactions

No Information Provided.

Mestinon Contraindications

Mestinon is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. Care should be observed in the use of atropine for counteracting side effects, as discussed below.

Manufacturers name:

  • Valeant Pharmaceuticals North America LLC

Generic name, Overdose, Half Life Mestinon, Food Interactions, Chemical, etc..

Mestinon see also FDA report

Brand Names containing Pyridostigmine
Hormones